Advisor Group’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$17K Hold
1,275
﹤0.01% 4051
2019
Q3
$20K Hold
1,275
﹤0.01% 3966
2019
Q2
$17K Hold
1,275
﹤0.01% 4073
2019
Q1
$22K Buy
+1,275
New +$20K ﹤0.01% 3936
2018
Q4
Sell
-2,662
Closed -$38K 5195
2018
Q3
$38K Hold
2,662
﹤0.01% 3479
2018
Q2
$40K Hold
2,662
﹤0.01% 3274
2018
Q1
$36K Hold
2,662
﹤0.01% 3321
2017
Q4
$63K Buy
2,662
+520
+24% +$12.3K ﹤0.01% 2923
2017
Q3
$40K Buy
2,142
+660
+45% +$15K ﹤0.01% 3102
2017
Q2
$51K Buy
+1,482
New +$40.7K ﹤0.01% 2847

Other funds holding PLSE

Advisor Group's PLSE Position: Q4 2019 in Review

Advisor Group held its Pulse Biosciences (PLSE) position steady in Q4 2019 at 1,275 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #4051.

Advisor Group first reported a position in PLSE in Q2 2017 and has held it in 10 quarters since. The position peaked at $63K in Q4 2017. 45 funds tracked by Wall St. Rank hold PLSE as of Q4 2019.

  • Advisor Group held 1,275 shares of Pulse Biosciences worth $17K as of Q4 2019.
  • Advisor Group left its Pulse Biosciences share count unchanged in Q4 2019.
  • Pulse Biosciences made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4051 holding.
  • Advisor Group first reported a position in Pulse Biosciences in Q2 2017 and has held it in 10 quarters since.
  • Advisor Group's Pulse Biosciences position peaked at $63K in Q4 2017.
  • 45 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.